NCTN: A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation (A071102)
Getting access
No access information recorded yet.
About this database
| Last updated | 2026-08-25 |
|---|